Πλοήγηση ανά Συγγραφέα "Oelke, M."
-
Current status of 5 alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH
Gravas, S.; Oelke, M. (2010)Benign prostatic hyperplasia (BPH) is a progressive disease that is commonly associated with bothersome lower urinary tract symptoms (LUTS) and might result in complications, such as acute urinary retention and BPH-related ... -
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction
Gratzke, C.; Bachmann, A.; Descazeaud, A.; Drake, M. J.; Madersbacher, S.; Mamoulakis, C.; Oelke, M.; Tikkinen, K. A. O.; Gravas, S. (2015)Context: Lower urinary tract symptoms (LUTS) represent one of the most common clinical complaints in adult men and have multifactorial aetiology. Objective: To develop European Association of Urology (EAU) guidelines on ... -
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
Oelke, M.; Bachmann, A.; Descazeaud, A.; Emberton, M.; Gravas, S.; Michel, M. C.; N'Dow, J.; Nordling, J.; de la Rosette, J. J. (2013)Objective: To present a summary of the 2013 version of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms (LUTS). Evidence acquisition: We conducted a literature ... -
Relevance of benign prostatic hyperplasia and associated conditions for urologists, health care systems, and society
Oelke, M.; Gravas, S. (2010)